OTUD6B and renal cell carcinoma: Gang Wang et al. suggested that OTUD6B-AS1 expression was downregulated in renal cell carcinoma via the Wnt/β-catenin signaling pathway and low expression of the transcript has been correlated with shorter overall survival than patients with high OTUD6B-AS1 expression [63].